-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Maintains Hold on Vanda Pharmaceuticals, Raises Price Target to $7.5

Benzinga·12/31/2025 12:29:38
Listen to the news
Jefferies analyst Chris Howerton maintains Vanda Pharmaceuticals (NASDAQ:VNDA) with a Hold and raises the price target from $5 to $7.5.